glutamic acid and Acute Relapsing Multiple Sclerosis

glutamic acid has been researched along with Acute Relapsing Multiple Sclerosis in 14 studies

Research

Studies (14)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (42.86)29.6817
2010's5 (35.71)24.3611
2020's3 (21.43)2.80

Authors

AuthorsStudies
Bellantonio, P; Buttari, F; Casamassa, A; Centonze, D; De Rosa, A; Di Maio, A; Errico, F; Fantozzi, R; Finardi, A; Furlan, R; Galifi, G; Gilio, L; Miroballo, M; Nuzzo, T; Stampanoni Bassi, M; Usiello, A1
Castañares, C; Cristiano, E; Lopez, PH; Pappolla, A; Patrucco, L; Rojas, JI; Sánchez, F; Varela, L1
C, B; C, F; Cp, Z; G, C; G, DC; M, C; M, F; M, G; M, R; M, S; R, F; S, A1
Barkhof, F; Eijlers, AJ; Geurts, JJ; Klauser, AM; Pouwels, PJ; Schoonheim, MM; Uitdehaag, BM; Wiebenga, OT1
Cao, G; Edden, RAE; Evans, AC; Gao, F; Li, H; Li, M; Wang, G; Wang, J; Xu, J; Yin, X; Zhao, B1
Atzori, M; Ciccarelli, O; De Vita, E; Geurts, JJ; Miller, DH; Muhlert, N; Samson, RS; Thomas, DL; Thompson, AJ; Wheeler-Kingshott, CA1
Falato, E; Filippi, MM; Ghazaryan, A; Landi, D; Mulas, D; Pasqualetti, P; Pellegrino, G; Rossini, PM; Vollaro, S1
Baranovičová, E; Bittšanský, M; Čierny, D; Hnilicová, P; Kantorová, E; Kurča, E; Nosáľ, V; Poláček, H; Sivák, Š; Zeleňák, K1
Westall, FC1
Green, AJ1
Altmann, DR; Chard, DT; Davies, G; Griffin, CM; McLean, MA; Miller, DH; Rashid, W; Sastre-Garriga, J; Thompson, AJ; Tiberio, M1
Domercq, M; Matute, C; Pampliega, O; Rodríguez-Antigüedad, A; Sepulcre, J; Villoslada, P1
Helms, G1
Bisaga, GN; Odinak, MM; Pozdniakov, AV; Tiutin, LA1

Other Studies

14 other study(ies) available for glutamic acid and Acute Relapsing Multiple Sclerosis

ArticleYear
Cerebrospinal fluid levels of L-glutamate signal central inflammatory neurodegeneration in multiple sclerosis.
    Journal of neurochemistry, 2021, Volume: 159, Issue:5

    Topics: Adult; Biomarkers; Cohort Studies; Female; Follow-Up Studies; Glutamic Acid; Humans; Inflammation Mediators; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neurodegenerative Diseases; Oxidative Stress

2021
[Prognostic value of cerebrospinal fluid glutamate in multiple sclerosis].
    Medicina, 2021, Volume: 81, Issue:5

    Topics: Glutamic Acid; Humans; Multiple Sclerosis; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Prognosis

2021
Platelet glutamate uptake and Th1 cells inversely correlate in relapsing/remitting and in progressive multiple sclerosis.
    Multiple sclerosis and related disorders, 2020, Volume: 41

    Topics: Adult; Blood Platelets; Female; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Inflammation; Male; Middle Aged; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Th1 Cells

2020
Metabolites predict lesion formation and severity in relapsing-remitting multiple sclerosis.
    Multiple sclerosis (Houndmills, Basingstoke, England), 2018, Volume: 24, Issue:4

    Topics: Adult; Brain; Choline; Diffusion Tensor Imaging; Female; Glutamic Acid; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis; Multiple Sclerosis, Relapsing-Remitting; Young Adult

2018
Altered hippocampal GABA and glutamate levels and uncoupling from functional connectivity in multiple sclerosis.
    Hippocampus, 2018, Volume: 28, Issue:11

    Topics: Adult; Brain Mapping; Cognition; Female; gamma-Aminobutyric Acid; Glutamic Acid; Hippocampus; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis, Relapsing-Remitting; Neural Pathways; Neuropsychological Tests; Rest

2018
Memory in multiple sclerosis is linked to glutamate concentration in grey matter regions.
    Journal of neurology, neurosurgery, and psychiatry, 2014, Volume: 85, Issue:8

    Topics: Adrenal Cortex Hormones; Adult; Age Factors; Brain Chemistry; Cognition; Female; Glutamic Acid; Humans; Image Processing, Computer-Assisted; Learning; Magnetic Resonance Imaging; Male; Memory; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Neuroimaging; Neuropsychological Tests

2014
Oral fingolimod reduces glutamate-mediated intracortical excitability in relapsing-remitting multiple sclerosis.
    Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology, 2015, Volume: 126, Issue:1

    Topics: Administration, Oral; Adult; Animals; Evoked Potentials, Motor; Female; Fingolimod Hydrochloride; Glutamic Acid; Humans; Immunosuppressive Agents; Male; Middle Aged; Motor Cortex; Multiple Sclerosis, Relapsing-Remitting; Propylene Glycols; Prospective Studies; Sphingosine; Transcranial Magnetic Stimulation

2015
Hypothalamic damage in multiple sclerosis correlates with disease activity, disability, depression, and fatigue.
    Neurological research, 2017, Volume: 39, Issue:4

    Topics: Adult; Aging; Aspartic Acid; Case-Control Studies; Choline; Creatine; Cross-Sectional Studies; Depression; Disability Evaluation; Fatigue; Female; Glutamic Acid; Humans; Hypothalamus; Inositol; Male; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Proton Magnetic Resonance Spectroscopy; Psychiatric Status Rating Scales; Severity of Illness Index

2017
A response to "Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis".
    Journal of neuroimmunology, 2008, Oct-15, Volume: 203, Issue:1

    Topics: Excitatory Amino Acid Transporter 2; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Multiple Sclerosis, Relapsing-Remitting; Polymorphism, Genetic

2008
Understanding pseudo: the symptoms are real, the cause is unclear.
    Neurology, 2009, May-12, Volume: 72, Issue:19

    Topics: Brain; Chemotaxis, Leukocyte; Clinical Trials as Topic; Encephalitis; Excitatory Amino Acid Antagonists; Glutamic Acid; Humans; Iatrogenic Disease; Inflammation Mediators; Memantine; Multiple Sclerosis, Relapsing-Remitting; Nystagmus, Pathologic; Secondary Prevention

2009
Metabolite changes in early relapsing-remitting multiple sclerosis. A two year follow-up study.
    Journal of neurology, 2006, Volume: 253, Issue:2

    Topics: Adult; Aspartic Acid; Choline; Creatine; Dipeptides; Female; Follow-Up Studies; Glutamic Acid; Humans; Image Processing, Computer-Assisted; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Statistics, Nonparametric; Time Factors

2006
Association of an EAAT2 polymorphism with higher glutamate concentration in relapsing multiple sclerosis.
    Journal of neuroimmunology, 2008, Volume: 195, Issue:1-2

    Topics: Adult; Aged; Cell Line, Transformed; Excitatory Amino Acid Transporter 2; Female; Gene Frequency; Genotype; Glutamate Plasma Membrane Transport Proteins; Glutamic Acid; Humans; Male; Middle Aged; Monocytes; Multiple Sclerosis, Relapsing-Remitting; Polymorphism, Genetic; T-Lymphocytes

2008
Volume correction for edema in single-volume proton MR spectroscopy of contrast-enhancing multiple sclerosis lesions.
    Magnetic resonance in medicine, 2001, Volume: 46, Issue:2

    Topics: Adult; Aspartic Acid; Brain; Case-Control Studies; Choline; Contrast Media; Creatine; Edema; Female; Gadolinium DTPA; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple Sclerosis, Relapsing-Remitting; Regression Analysis; Signal Processing, Computer-Assisted

2001
[Proton magnetic-resonance spectroscopy in remitting and secondary-progressive multiple sclerosis].
    Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2001, Volume: 101, Issue:4

    Topics: Adolescent; Adult; Aspartic Acid; Brain; Choline; Creatine; Demyelinating Diseases; Female; gamma-Aminobutyric Acid; Glutamic Acid; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Multiple Sclerosis, Chronic Progressive; Multiple Sclerosis, Relapsing-Remitting; Phosphocreatine; Severity of Illness Index

2001